Sort
39,280 grants matching “leukemia”
Project 2: REG3A Regulation of GI GVHD
$397,086James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2016 · CA
Project 2: REG3A Regulation of GI GVHD
$397,086James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2017 · CA
HYDROXYCHLOROQUINE THERAPY AND BIOLOGY OF GVHD
$397,082Children'S Mercy Hosp (Kansas City, Mo) · R01 · FY2001 · CA
Physiologic Regulation of Hematopoiesis by Notch
$397,080Nadia Carlesso · Indiana University Indianapolis · R01 · FY2014 · DK
Epigenetic, Transcriptional, and Microenvironmental Determinants of Human HSC Self-Renewal
$397,048Ravindra Majeti · Stanford University · R01 · FY2018 · HL
Molecular Mechanisms of eIF4E Mediated Transformation
$397,035Katherine L B Borden · Northwestern University At Chicago · R01 · FY2025 · CA
Distinct acute myeloid leukemia subclasses with CEBPA mutations
$397,021Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2011 · CA
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
$396,986Andrew A Lane · Dana-Farber Cancer Inst · R37 · FY2021 · CA
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
$396,986Andrew A Lane · Dana-Farber Cancer Inst · R37 · FY2018 · CA
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
$396,986Andrew A Lane · Dana-Farber Cancer Inst · R37 · FY2022 · CA
The Role of Wnt Signaling in Normal and Abnormal Hematopoiesis
$396,986Stephanie Laura Grainger · Van Andel Research Institute · R00 · FY2021 · HL
A Precision Medicine Tool for Optimal Personalized Treatment in Patients with Acute Myeloid Leukemia
$396,908Athanasios Mantalaris · Sanicka, Inc · R42 · FY2022 · CA
Tissue-specific tumor suppressor effects of p53
$396,908James J. Manfredi · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Differential GVHD induction by naive and memory T cells
$396,896Mark J Shlomchik · Yale University · R01 · FY2007 · HL
Differential GVHD induction by naive and memory T cells
$396,896Mark J Shlomchik · Yale University · R01 · FY2008 · HL
Differential GVHD induction by naive and memory T cells
$396,896Mark J Shlomchik · Yale University · R01 · FY2009 · HL
Inhibition of viral entry by interferon-induced proteins
$396,876Gregory B Melikian · Emory University · R01 · FY2019 · AI
Epigenetic Mechanisms Underpinning Mantle Cell Lymphoma Sensitivity and Resistance to Notch Inhibitors
$396,850Robert Babak Faryabi · University Of Pennsylvania · R01 · FY2024 · CA
GALV-Based Retroviral Replicating Vectors for Glioma Gene Therapy
$396,833Noriyuki Kasahara · University Of California, San Francisco · R21 · FY2020 · NS
Defining the impact of mutant oncogene zygosity
$396,790Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
APOBEC proteins as drivers of chromosomal translocations in solid cancers
$396,790Roberto Chiarle · Boston Children'S Hospital · R01 · FY2022 · CA
Defining the impact of mutant oncogene zygosity
$396,790Sarat Chandarlapaty · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Prognostic markers in postoperative acute kidney injury
$396,780John M. Arthur · Medical University Of South Carolina · R01 · FY2008 · DK
Mechanistic Study of PEG-asparaginase-Induced Liver Injury
$396,750Christian Antonio Fernandez · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Mechanistic Study of PEG-asparaginase-Induced Liver Injury
$396,750Christian Antonio Fernandez · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK